Patent ID: 8357721

Claim:
A method for treating retinopathy comprising administering a compound of the formula (I): in which formula (I): R1 represents a group of the formula: —X—(Y) m , in which: —X— represents an aryl, cycloalkyl, heteroaryl, alkyl or heterocyclyl group; Each of the groups Y, which may be identical or different, independently represents a halogen atom or an -alkyl, —O-alkyl, —CO-alkyl, —NO 2 , —O-perhaloalkyl, —S(O) q -alkyl or -perhaloalkyl group, or two groups Y together form an aryl or heteroaryl group fused to the phenyl nucleus to which they are attached; m represents an integer chosen from 0, 1, 2, 3, 4 and 5; R2 and R3 together form a cycloalkyl or heterocyclyl group optionally substituted by one or more alkyl groups; R4 represents a group of the formula -Z-(alkyl) n -T p in which -Z- represents —O— or a group —S(O) q — or, if n=p=0, a halogen atom or an —OH group; T represents a cycloalkyl, heterocyclyl or heteroaryl group; n represents an integer chosen from 0 and 1; p represents an integer chosen from 0 and 1; i represents an integer greater than or equal to 2; R5 represents a hydrogen atom or an alkyl group, optionally substituted by one or more cycloalkyl groups; each of the groups R6, which may be identical or different, independently represents a group chosen from alkyl, O-alkyl, a halogen atom and a —CN, —NO 2 , —CO-alkyl, —CO 2 R, —NRR′, —O-perhaloalkyl or -perhaloalkyl group; j represents an integer chosen between 0, 1, 2, 3 and 4; R and R′, which may be identical or different, independently represent a hydrogen atom or an alkyl group; and q represents an integer chosen from 0, 1 and 2; or a tautomeric, enantiomeric, diastereoisomeric or epimeric form thereof, or a pharmaceutically acceptable salt thereof; with the exception of the compounds for which R4 represents an —OH group or an —O-tetrahydropyran group.